Vir Biotechnology (NASDAQ:VIR) Price Target Lowered to $21.00 at The Goldman Sachs Group
Vir Biotechnology (NASDAQ:VIR – Free Report) had its price target decreased by The Goldman Sachs Group from $28.00 to $21.00 in a research note issued to investors on Thursday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock. A number of other equities analysts have also weighed in on the […]
Vir Biotechnology (NASDAQ:VIR – Free Report) had its price target decreased by The Goldman Sachs Group from $28.00 to $21.00 in a research note issued to investors on Thursday morning,Benzinga reports. The Goldman Sachs Group currently has a buy rating on the stock. A number of other equities analysts have also weighed in on the […]
